国产精品久久久久久亚洲,国产成人无码午夜视频在线观看 ,国产福利一区二区三区在线观看,国产av第一次处破,厨房玩弄丝袜人妻系列国产电影

首頁(yè) >>> 產(chǎn)品目錄 >>> **學(xué) >>> 單克隆抗體
儀表展覽網(wǎng) >>> 展館展區(qū) >>> 試劑 >>> **試劑 >>> 血小板源性生長(zhǎng)因子受體A/PDGFRα抗體
> 血小板源性生長(zhǎng)因子受體A/PDGFRα抗體

產(chǎn)品資料

血小板源性生長(zhǎng)因子受體A/PDGFRα抗體

血小板源性生長(zhǎng)因子受體A/PDGFRα抗體
  • 如果您對(duì)該產(chǎn)品感興趣的話,可以
  • 產(chǎn)品名稱:血小板源性生長(zhǎng)因子受體A/PDGFRα抗體
  • 產(chǎn)品型號(hào):
  • 產(chǎn)品展商:單克隆抗體/多克隆抗體
  • 產(chǎn)品文檔:無(wú)相關(guān)文檔
??單介紹
血小板源性生長(zhǎng)因子受體A/PDGFRα抗體應(yīng)用于IHC、WB、 IF、IP、ELISA等科研實(shí)驗(yàn),按理化性質(zhì)和生物學(xué)功能IgM、IgG、IgA、IgE、IgD五類。按抗體的來(lái)源,可將其分為天然抗體和**抗體。血小板源性生長(zhǎng)因子受體A/PDGFRα抗體生產(chǎn)每個(gè)流程都執(zhí)行嚴(yán)格的檢測(cè)標(biāo)準(zhǔn),保證蛋白抗原產(chǎn)品質(zhì)量,質(zhì)量穩(wěn)定,實(shí)驗(yàn)效果明顯。
產(chǎn)品描述

血小板源性生長(zhǎng)因子受體A/PDGFRα抗體


規(guī)格:1mg/1ml

英文名: PDGFRA

別名: PDGF Receptor alpha; Platelet–dirived growth factor receptor-alpha; Alpha platelet derived growth factor receptor; CD 140a; CD140a; CD140a antigen; MGC74795; PDGF alpha chain; PDGF R alpha; PDGFR 2; P

分子量: 117kDa

克隆類型:Polyclonal

亞型:IgG

純化方法:affinity purified by Protein A

**原:KLH conjugated synthetic peptide derived from human PDGF-R-A

交叉反應(yīng):Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse,

血小板源性生長(zhǎng)因子受體A/PDGFRα抗體細(xì)胞定位:細(xì)胞膜

產(chǎn)品介紹:background: This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]. Function: Tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis. Depending on the context, promotes or inhibits cell proliferation and cell migration. Plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells. Required for normal skeleton development and cephalic closure during embryonic development. Required for normal development of the mucosa lining the gastrointestinal tract, and for recruitment of mesenchymal cells and normal development of intestinal villi. Plays a role in cell migration and chemotaxis in wound healing. Plays a role in platelet activation, secretion of agonists from platelet granules, and in thrombin-induced platelet aggregation.血小板源性生長(zhǎng)因子受體A/PDGFRα抗體 Binding of its cognate ligands - homodimeric PDGFA, homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFC -leads to the activation of several signaling cascades; the response depends on the nature of the bound ligand and is modulated by the formation of heterodimers between PDGFRA and PDGFRB. Phosphorylates PIK3R1, PLCG1, and PTPN11. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the activation of protein kinase C. Phosphorylates PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and thereby mediates activation of the AKT1 signaling pathway. Mediates activation of HRAS and of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3 and STAT5A and/or STAT5B. Receptor signaling is down-regulated by protein phosphatases that dephosphorylate the receptor and its down-stream effectors, and by rapid internalization of the activated receptor. Subunit: Interacts with homodimeric PDGFA, PDGFB and PDGFC, and with heterodimers formed by PDGFA and PDGFB. Monomer in the absence of bound ligand. Interaction with dimeric PDGFA, PDGFB and/or PDGFC leads to receptor dimerization, where both PDGFRA homodimers and heterodimers with PDGFRB are observed. Interacts (tyrosine phosphorylated) with SHB (via SH2 domain). Interacts (tyrosine phosphorylated) with SHF (via SH2 domain). Interacts (tyrosine phosphorylated) with SRC (via SH2 domain). Interacts (tyrosine phosphorylated) with PIK3R1. Interacts (tyrosine phosphorylated) with PLCG1 (via SH2 domain). Interacts (tyrosine phosphorylated) with CRK, GRB2 and GRB7. Interacts with human cytomegalovirus/HHV-5 envelop glycoprotein B/gB. Subcellular Location: Cell membrane; Single-pass type I membrane protein. Note=The activated receptor is rapidly internalized and degraded. Tissue Specificity: Detected in platelets (at protein level). Widely expressed. Detected in brain, fibroblasts, smooth muscle, heart, and embryo. Expressed in primary and metastatic colon tumors and in normal colon tissue. Post-translational modifications: N-glycosylated. Ubiquitinated, leading to its degradation (Probable). Autophosphorylated on tyrosine residues upon ligand binding. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit. Phosphorylation at Tyr-731 and Tyr-742 is important for interaction with PIK3R1. Phosphorylation at Tyr-720 and Tyr-754 is important for interaction with PTPN11. Phosphorylation at Tyr-762 is important for interaction with CRK. Phosphorylation at Tyr-572 and Tyr-574 is important for interaction with SRC and SRC family members. Phosphorylation at Tyr-988 and Tyr-1018 is important for interaction with PLCG1. DISEASE: Note=A chromosomal aberration involving PDGFRA is found in some cases of hypereosinophilic syndrome. Interstitial chromosomal deletion del(4)(q12q12) causes the fusion of FIP1L1 and血小板源性生長(zhǎng)因子受體A/PDGFRα抗體 PDGFRA (FIP1L1-PDGFRA). Mutations that cause overexpression and/or constitutive activation of PDGFRA may be a cause of hypereosinophilic syndrome. Defects in PDGFRA are a cause of gastrointestinal stromal tumor (GIST) [MIM:606764]. Note=Mutations that cause constitutive activation of PDGFRA may be a cause of gastrointestinal stromal tumor (GIST). Similarity: Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily. Contains 5 Ig-like C2-type (immunoglobulin-like) domains. Contains 1 protein kinase domain. Gene ID: 5156 Database links: Entrez Gene: 5156 Human Entrez Gene: 18595 Mouse Entrez Gene: 25267 Rat Omim: 173490 Human SwissProt: P16234 Human SwissProt: P26618 Mouse SwissProt: P20786 Rat Unigene: 74615 Human Unigene: 221403 Mouse Unigene: 55127 Rat Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 細(xì)胞膜受體(Membrane Receptors) PDGFR-α是膜受體,具有酪氨酸酶的活性,與其配體PDGF結(jié)合后激活與細(xì)胞增殖有關(guān)的酶及基因。 PDGFR亦表達(dá)于上皮、內(nèi)皮細(xì)胞,前列腺、皮膚、腎小球等上皮細(xì)胞均有PDGFR表達(dá). 亦有學(xué)者報(bào)道血小板源性生長(zhǎng)因子受體α抗體在細(xì)胞胞漿胞膜、胞核都有不同的表達(dá) 還有人認(rèn)為:PDGF及其受體一般表達(dá)于浸潤(rùn)病變組織的炎癥細(xì)胞附近,組織缺血損傷、腎小球高壓、**因素作用、炎癥細(xì)胞浸潤(rùn)、實(shí)質(zhì)細(xì)胞活化等導(dǎo)致PDGFR表達(dá)增強(qiáng)

血小板源性生長(zhǎng)因子受體A/PDGFRα抗體產(chǎn)品應(yīng)用:WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復(fù)) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.

研究領(lǐng)域:心血管  信號(hào)轉(zhuǎn)導(dǎo)  生長(zhǎng)因子和**  

儲(chǔ)存條件: Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.

來(lái)源: Rabbit

外觀: Lyophilized or Liquid


產(chǎn)品留言
標(biāo)題
聯(lián)系人
聯(lián)系電話
內(nèi)容
驗(yàn)證碼
點(diǎn)擊換一張
注:1.可以使用快捷鍵Alt+S或Ctrl+Enter發(fā)送信息!
2.如有必要,請(qǐng)您留下您的詳細(xì)聯(lián)系方式!
  • 溫馨提示:為規(guī)避購(gòu)買(mǎi)風(fēng)險(xiǎn),建議您在購(gòu)買(mǎi)前務(wù)必確認(rèn)供應(yīng)商資質(zhì)與產(chǎn)品質(zhì)量。
  • 免責(zé)申明:以上內(nèi)容為注冊(cè)會(huì)員自行發(fā)布,若信息的真實(shí)性、合法性存在爭(zhēng)議,平臺(tái)將會(huì)監(jiān)督協(xié)助處理,歡迎舉報(bào)
產(chǎn)品留言
標(biāo)題
內(nèi)容
聯(lián)系人
聯(lián)系電話
電子郵件
公司名稱
聯(lián)系地址
驗(yàn)證碼
點(diǎn)擊換一張
注:1.可以使用快捷鍵Alt+S或Ctrl+Enter發(fā)送信息!
2.如有必要,請(qǐng)您留下您的詳細(xì)聯(lián)系方式!